These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25068589)

  • 1. Carbohydrate-functionalized nanovaccines preserve HIV-1 antigen stability and activate antigen presenting cells.
    Vela Ramirez JE; Roychoudhury R; Habte HH; Cho MW; Pohl NL; Narasimhan B
    J Biomater Sci Polym Ed; 2014; 25(13):1387-406. PubMed ID: 25068589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mannose-functionalized "pathogen-like" polyanhydride nanoparticles target C-type lectin receptors on dendritic cells.
    Carrillo-Conde B; Song EH; Chavez-Santoscoy A; Phanse Y; Ramer-Tait AE; Pohl NL; Wannemuehler MJ; Bellaire BH; Narasimhan B
    Mol Pharm; 2011 Oct; 8(5):1877-86. PubMed ID: 21882825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailoring the immune response by targeting C-type lectin receptors on alveolar macrophages using "pathogen-like" amphiphilic polyanhydride nanoparticles.
    Chavez-Santoscoy AV; Roychoudhury R; Pohl NL; Wannemuehler MJ; Narasimhan B; Ramer-Tait AE
    Biomaterials; 2012 Jun; 33(18):4762-72. PubMed ID: 22465338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionalization of polyanhydride microparticles with di-mannose influences uptake by and intracellular fate within dendritic cells.
    Phanse Y; Carrillo-Conde BR; Ramer-Tait AE; Roychoudhury R; Pohl NL; Narasimhan B; Wannemuehler MJ; Bellaire BH
    Acta Biomater; 2013 Nov; 9(11):8902-9. PubMed ID: 23796408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionalization promotes pathogen-mimicking characteristics of polyanhydride nanoparticle adjuvants.
    Phanse Y; Carrillo-Conde BR; Ramer-Tait AE; Roychoudhury R; Broderick S; Pohl N; Rajan K; Narasimhan B; Wannemuehler MJ; Bellaire BH
    J Biomed Mater Res A; 2017 Oct; 105(10):2762-2771. PubMed ID: 28556563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticles.
    Vela-Ramirez JE; Goodman JT; Boggiatto PM; Roychoudhury R; Pohl NL; Hostetter JM; Wannemuehler MJ; Narasimhan B
    AAPS J; 2015 Jan; 17(1):256-67. PubMed ID: 25421457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput synthesis of carbohydrates and functionalization of polyanhydride nanoparticles.
    Carrillo-Conde BR; Roychoudhury R; Chavez-Santoscoy AV; Narasimhan B; Pohl NL
    J Vis Exp; 2012 Jul; (65):. PubMed ID: 22806007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyanhydride Nanovaccines Induce Germinal Center B Cell Formation and Sustained Serum Antibody Responses.
    Vela Ramirez JE; Tygrett LT; Hao J; Habte HH; Cho MW; Greenspan NS; Waldschmidt TJ; Narasimhan B
    J Biomed Nanotechnol; 2016 Jun; 12(6):1303-11. PubMed ID: 27319223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccination.
    Aline F; Brand D; Pierre J; Roingeard P; Séverine M; Verrier B; Dimier-Poisson I
    Vaccine; 2009 Aug; 27(38):5284-91. PubMed ID: 19450633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemistry-dependent adsorption of serum proteins onto polyanhydride microparticles differentially influences dendritic cell uptake and activation.
    Carrillo-Conde BR; Ramer-Tait AE; Wannemuehler MJ; Narasimhan B
    Acta Biomater; 2012 Oct; 8(10):3618-28. PubMed ID: 22684115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyanhydride microparticles enhance dendritic cell antigen presentation and activation.
    Torres MP; Wilson-Welder JH; Lopac SK; Phanse Y; Carrillo-Conde B; Ramer-Tait AE; Bellaire BH; Wannemuehler MJ; Narasimhan B
    Acta Biomater; 2011 Jul; 7(7):2857-64. PubMed ID: 21439412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants.
    Petersen LK; Ramer-Tait AE; Broderick SR; Kong CS; Ulery BD; Rajan K; Wannemuehler MJ; Narasimhan B
    Biomaterials; 2011 Oct; 32(28):6815-22. PubMed ID: 21703679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced in vivo targeting of murine nonparenchymal liver cells with monophosphoryl lipid A functionalized microcapsules.
    Pietrzak-Nguyen A; Fichter M; Dedters M; Pretsch L; Gregory SH; Meyer C; Doganci A; Diken M; Landfester K; Baier G; Gehring S
    Biomacromolecules; 2014 Jul; 15(7):2378-88. PubMed ID: 24901387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-functional nanocomplex codelivery of Trp2 and R837 to activate melanoma-specific immunity.
    Ji Z; Tan Z; Li M; Tao J; Guan E; Du J; Hu Y
    Int J Pharm; 2020 May; 582():119310. PubMed ID: 32276088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Characterization of Rapidly Degrading Polyanhydrides as Vaccine Adjuvants.
    Kelly SM; Mitra A; Mathur S; Narasimhan B
    ACS Biomater Sci Eng; 2020 Jan; 6(1):265-276. PubMed ID: 33463223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A.
    Idoyaga J; Lubkin A; Fiorese C; Lahoud MH; Caminschi I; Huang Y; Rodriguez A; Clausen BE; Park CG; Trumpfheller C; Steinman RM
    Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2384-9. PubMed ID: 21262813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-based vaccine nanoparticles for induction of humoral immune responses against HIV-1 and SARS-CoV-2.
    Park KS; Bazzill JD; Son S; Nam J; Shin SW; Ochyl LJ; Stuckey JA; Meagher JL; Chang L; Song J; Montefiori DC; LaBranche CC; Smith JL; Xu J; Moon JJ
    J Control Release; 2021 Feb; 330():529-539. PubMed ID: 33358977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The differences in immunoadjuvant mechanisms of TLR3 and TLR4 agonists on the level of antigen-presenting cells during immunization with recombinant adenovirus vector.
    Lebedeva E; Bagaev A; Pichugin A; Chulkina M; Lysenko A; Tutykhina I; Shmarov M; Logunov D; Naroditsky B; Ataullakhanov R
    BMC Immunol; 2018 Jul; 19(1):26. PubMed ID: 30055563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants.
    Ulery BD; Petersen LK; Phanse Y; Kong CS; Broderick SR; Kumar D; Ramer-Tait AE; Carrillo-Conde B; Rajan K; Wannemuehler MJ; Bellaire BH; Metzger DW; Narasimhan B
    Sci Rep; 2011; 1():198. PubMed ID: 22355713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-glycosylation converts non-glycoproteins into mannose receptor ligands and reveals antigen-specific T cell responses in vivo.
    Kreer C; Kuepper JM; Zehner M; Quast T; Kolanus W; Schumak B; Burgdorf S
    Oncotarget; 2017 Jan; 8(4):6857-6872. PubMed ID: 28036287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.